GLP-1 medications like Ozempic, Wegovy, and Zepbound have become some of the most talked-about treatments for weight loss, but their benefits may extend far beyond the scale.
In this episode, Diana breaks down what GLP-1 medications are, how they work in the body, and what current research shows about kidney health. She explores the growing evidence for kidney protection, discusses emerging research in autosomal dominant polycystic kidney disease (ADPKD), and shares practical considerations for people with PKD who are considering semaglutide or tirzepatide medications.
SHOW NOTES, REFERENCES, & TRANSCRIPTS
www.thepkddietitian.com/58 Episode #57: Weight Loss & PKD: Can It Slow Kidney Growth and Disease Progression? GLP1 Clinical Trial: Glucagon-Like Peptide-1 Receptor Agonist in ADPKDFLOW Trial: https://pubmed.ncbi.nlm.nih.gov/38785209/ Support the Show: patreon.com/PKDDietitianWORK WITH DIANA: thepkddietitian.com/workwithme
HAVE A QUESTION? Send a message to [email protected]
FIND THE PKD DIETITIAN ONLINE
Patreon: PKDDietitianInstagram: @The.PKD.DietitianFacebook: The PKD DietitianWebsite: thepkddietitian.comSupport the show and access future bonus content and deeper PKD nutrition insights: patereon.com/PKDDietitian
The PKD Dietitian Podcast is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.